Page 1

MEDICOVER INTERIM REPORT JANUARY - MARCH 2021 . • . Revenue amounted to € 317.2m ( € 238.8m ) , an increase of 32.8 % with an organic growth of 39.7 % . Operating profit ( EBIT ) was € 41.6m ( € 6.4m ) , representing an operating margin of 13.1 % ( 2.7 % ) . Net profit amounted to € 26.3m ( € -2.5m ) , which represents a net profit margin of 8.3 % ( -1.0 % ) . EBITDA was € 65.5m ( € 29.0m ) , an increase of 125.6 % . EBITDA margin was 20.6 % ( 12.2 % ) . • EBITDAAL amounted to € 52.9m ( € 16.8m ) , corresponding to an EBITDAAL margin of 16.7 % ( 7.0 % ) . Net cash flow from operating activities was € 57.7m ( € 36.6m ) . Basic / diluted earnings per share were € 0.174 ( € -0.006 ) . Covid - 19 - pandemic had a net positive impact on operating performance . REVENUE AND EARNINGS € millions ( € m ) Q1 2021 Q1 2020 Growth FY 2020 Revenue Operating profit ( EBIT ) 317.2 41.6 238.8 33 % 997.8 6.4 550 % 61.3 Operating profit margin 13.1 % 2.7 % 6.1 % Net profit 26.3 -2.5 1,152 % 27.3 Net profit margin 8.3 % -1.0 % 2.7 % Basic / diluted earnings per share , € 0.174 -0.006 3,000 % 0.182 EBITDA 65.5 29.0 126 % 157.5 EBITDA margin 20.6 % 12.2 % 15.8 % EBITDAAL 52.9 16.8 215 % 108.5 EBITDAAL margin 16.7 % 7.0 % 10.9 % EBITA EBITA margin 44.1 13.9 % 8.9 396 % 3.7 % 76.9 7.7 % Definition and reconciliation of alternative performance measures are available at www.medicover.com/financial-information . Medicover is a leading international healthcare and diagnostic services company and was founded in 1995. Medicover operates a large number of ambulatory clinics , hospitals , specialty - care facilities , laboratories and blood - drawing points and the largest markets are Poland and Germany . In 2020 , Medicover had revenue of EUR 998 million and more than 32,000 employees . For more information , go to www.medicover.com Medicover AB ( Publ ) | P.O. Box 5283 SE - 102 46 Stockholm | Visiting address : Riddargatan 12A | Sweden 1